BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36870799)

  • 1. Global Medical Device Clinical Trials Involving Both the United States and Japan: Key Considerations for Development, Regulatory Approval, and Conduct.
    Iwamoto S; Cavanaugh K; Malone M; Lottes A; Thatcher R; Kumar K; Rowland S; Fearnot N; Uchida T; Iwaishi C; Senshu K; Konishi R; Ikeda K; Suzuki Y; Ikeno F; Tamura A; Ho M; Ohashi M; Katayama H; Krucoff MW
    Cardiovasc Revasc Med; 2023 Jul; 52():67-74. PubMed ID: 36870799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New Medical Device Evaluation].
    Ikeda K
    Yakugaku Zasshi; 2016; 136(4):527-30. PubMed ID: 27040333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partnership Between Japan and the United States for Early Development of Pediatric Medical Devices - Harmonization By Doing for Children.
    Takahashi S; Ibrahim N; Yasukochi S; Ringel R; Ing F; Tomita H; Sugiyama H; Yamagishi M; Forbes TJ; Kim SH; Ho M; Gillette N; Nakamura Y; Mineta K; Fearnot N; Dineen D; Vang E; Haskin R; Becker LAM; Sekiguchi K; Sakamoto K; Ruiz CE;
    Circ J; 2020 Apr; 84(5):786-791. PubMed ID: 32238666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japan-USA Orbital Atherectomy for Calcific Coronary Lesions: COAST Study, a Harmonization by Doing Proof-of-Concept: The Japanese and US Regulatory Perspective.
    Iwamoto S; Ohashi M; Shirato H; Ho M; Malone M; Cavanaugh K
    Cardiovasc Revasc Med; 2022 Apr; 37():118-119. PubMed ID: 34483075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of supportive regulatory measures for pediatric medical device development in Japan and the United States.
    Takahashi S; Iwasaki K; Shirato H; Ho M; Umezu M
    J Artif Organs; 2021 Mar; 24(1):90-101. PubMed ID: 33079285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design Strategies for Global Clinical Trials of Endovascular Devices for Critical Limb Ischemia (CLI) - A Joint USA-Japanese Perspective.
    Yokoi H; Ho M; Iwamoto S; Suzuki Y; Ansel GM; Azuma N; Handa N; Iida O; Ikeda K; Ikeno F; Ohura N; Rosenfield K; Rundback J; Terashi H; Uchida T; Yokoi Y; Nakamura M; Jaff MR
    Circ J; 2018 Aug; 82(9):2233-2239. PubMed ID: 29962385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global cardiovascular device innovation: Japan-USA synergies: Harmonization by Doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions.
    Uchida T; Ikeno F; Ikeda K; Suzuki Y; Todaka K; Yokoi H; Thompson G; Krucoff M; Saito S;
    Circ J; 2013; 77(7):1714-8. PubMed ID: 23538483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japan-USA Orbital Atherectomy for Calcific Coronary Lesions: COAST Study, Harmonization by Doing Proof-of-Concept.
    Martinsen BJ; Kumar K; Saito S; Sharma SK; Ikeno F; Fearnot NE; Shlofmitz RA; Thatcher R; Krucoff MW
    Cardiovasc Revasc Med; 2022 Apr; 37():112-117. PubMed ID: 34607786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating comparative evidence on new drugs and devices after approval.
    Cipriani A; Ioannidis JPA; Rothwell PM; Glasziou P; Li T; Hernandez AF; Tomlinson A; Simes J; Naci H
    Lancet; 2020 Mar; 395(10228):998-1010. PubMed ID: 32199487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Globalization of Medical Device Clinical Development Programs in Japan - The Case of Drug-Eluting Stents.
    Murakami M; Suzuki Y; Tominaga T
    Circ J; 2018 Feb; 82(3):636-643. PubMed ID: 28883226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiology devices and the regulatory approval process within the U.S. FDA and abroad.
    Selzman KA; Patel H; Cavanaugh K
    J Interv Card Electrophysiol; 2019 Nov; 56(2):173-182. PubMed ID: 31418099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax.
    BioDrugs; 2003; 17(1):69-72. PubMed ID: 12534322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiregional medical device development: regulatory perspective.
    Tamura A; Kutsumi H
    Clin J Gastroenterol; 2014 Apr; 7(2):108-16. PubMed ID: 26183624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J-TVT.
    Kaneko T; Vemulapalli S; Kohsaka S; Shimamura K; Stebbins A; Kumamaru H; Nelson AJ; Kosinski A; Maeda K; Bavaria JE; Saito S; Reardon MJ; Kuratani T; Popma JJ; Inohara T; Thourani VH; Carroll JD; Shimizu H; Takayama M; Leon MB; Mack MJ; Sawa Y
    J Am Heart Assoc; 2022 Mar; 11(6):e023848. PubMed ID: 35243902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making.
    Coppens DGM; de Wilde S; Guchelaar HJ; De Bruin ML; Leufkens HGM; Meij P; Hoekman J
    Cytotherapy; 2018 Jun; 20(6):769-778. PubMed ID: 29730080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
    Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
    Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future.
    Ohashi T; Nagashima M; Kawai N; Ohmagari N; Tateda K
    Expert Rev Anti Infect Ther; 2022 Dec; 20(12):1603-1614. PubMed ID: 36368311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.